XML 141 R16.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Goodwill And Other Intangible Assets
 12 Months Ended
Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill And Other Intangible Assets Goodwill and Other Intangible Assets
A summary of the change in the carrying amount of goodwill for our segments (see Note 19, “Segment Information”) for 2019 and 2018 is as follows:
 
Commercial
and Specialty
Business
 
Government
Business
 
Other
 
Total
Balance as of January 1, 2018
$
11,818

 
$
7,402

 
$
11

 
$
19,231

Acquisitions
—

 
1,285

 
—

 
1,285

Adjustments
(267
)
 
266

 
(11
)
 
(12
)
Balance as of December 31, 2018
11,551

 
8,953

 
—

 
20,504

Adjustments
—

 
(674
)
 
670

 
(4
)
Balance as of December 31, 2019
$
11,551

 
$
8,279

 
$
670

 
$
20,500

Accumulated impairment as of December 31, 2019
$
(41
)
 
$
—

 
$
—

 
$
(41
)

The increase in goodwill in 2018 was primarily due to the acquisition of America’s 1st Choice in February 2018. For additional information regarding this acquisition, see Note 3, “Business Acquisitions”.
Goodwill adjustments in 2019 include certain reclassifications made for changes in segment reporting. The adjustments in 2018 include measurement period adjustments for HealthSun as well as certain reclassifications made for changes in segment reporting. For additional information, see Note 19, “Segment Information”.
As required by FASB guidance, we completed annual impairment tests of existing goodwill and other intangible assets with indefinite lives during 2019, 2018 and 2017. We perform these annual impairment tests during the fourth quarter. FASB guidance also requires interim impairment testing to be performed when potential impairment indicators exist. These tests involve the use of estimates related to the fair value of goodwill and intangible assets with indefinite lives and require a significant degree of management judgment and the use of subjective assumptions. Qualitative testing procedures include assessing our financial performance, macroeconomic conditions, industry and market considerations, various asset specific factors and entity specific events. For quantitative testing, the fair values are estimated using the projected income and market valuation approaches, incorporating Level III internal estimates for inputs, including, but not limited to, revenue projections, income projections, cash flows and discount rates. We did not incur any impairment losses in 2019, 2018 or 2017, as the estimated fair values of our reporting units were substantially in excess of their carrying values.
The components of other intangible assets as of December 31, 2019 and 2018 are as follows:
 
2019
 
2018
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
Intangible assets with finite lives:
 
 
 
 
 
 
 
 
 
 
 
Customer relationships
$
4,500

 
$
(3,469
)
 
$
1,031

 
$
4,495

 
$
(3,185
)
 
$
1,310

Provider and hospital relationships
228

 
(98
)
 
130

 
228

 
(85
)
 
143

Other
352

 
(129
)
 
223

 
352

 
(88
)
 
264

Total
5,080

 
(3,696
)
 
1,384

 
5,075

 
(3,358
)
 
1,717

Intangible assets with indefinite lives:
 
 
 
 
 
 
 
 
 
 
 
Blue Cross and Blue Shield and other trademarks
6,299

 
—

 
6,299

 
6,299

 
—

 
6,299

State Medicaid licenses
991

 
—

 
991

 
991

 
—

 
991

Total
7,290

 
—

 
7,290

 
7,290

 
—

 
7,290

Other intangible assets
$
12,370

 
$
(3,696
)
 
$
8,674

 
$
12,365

 
$
(3,358
)
 
$
9,007


As of December 31, 2019, the estimated amortization expense for each of the five succeeding years is as follows: 2020, $290; 2021, $244; 2022, $195; 2023, $162; and 2024, $85.